Artificial intelligence in cardiovascular prevention: new ways will open new doors

被引:0
作者
Ciccarelli, Michele [1 ,9 ]
Giallauria, Francesco [2 ]
Carrizzo, Albino [1 ,3 ]
Visco, Valeria [1 ]
Silverio, Angelo [1 ]
Cesaro, Arturo [4 ]
Calabro, Paolo [4 ]
De Luca, Nicola [5 ]
Mancusi, Costantino [5 ]
Masarone, Daniele [6 ]
Pacileo, Giuseppe [6 ]
Tourkmani, Nidal [7 ,8 ]
Vigorito, Carlo [2 ]
Vecchione, Carmine [1 ,3 ]
机构
[1] Univ Salerno, Dept Med Surg & Dent, Baronissi, Italy
[2] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[3] IRCCS Neuromed, Vasc Physiopathol Unit, Pozzilli, Italy
[4] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy
[5] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[6] AORN Colli Monaldi Hosp Naples, Dept Cardiol, Heart Failure Unit, Naples, Italy
[7] Mons Giosue Calaciura Clin, Cardiol & Cardiac Rehabil Unit, Catania, Italy
[8] ABL, Guangzhou, Peoples R China
[9] Univ Salerno, Dept Med Surg & Dent, Via Salvador Allende, I-84081 Salerno, Italy
关键词
artificial intelligence; atrial fibrillation; cardiovascular prevention; coronary artery disease; heart failure; hypertension; machine learning; personalized medicine; risk stratification; LATE GADOLINIUM ENHANCEMENT; AMERICAN-HEART-ASSOCIATION; SUDDEN CARDIAC DEATH; ESC WORKING GROUP; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; POSITION STATEMENT; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; TASK-FORCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.
引用
收藏
页码:e106 / e115
页数:10
相关论文
共 50 条
  • [41] Artificial Intelligence in Cardiovascular Clinical Trials
    Cunningham, Jonathan W.
    Abraham, William T.
    Bhatt, Ankeet S.
    Dunn, Jessilyn
    Felker, G. Michael
    Jain, Sneha S.
    Lindsell, Christopher J.
    Mace, Matthew
    Martyn, Trejeeve
    Shah, Rashmee U.
    Tison, Geoffrey H.
    Fakhouri, Tala
    Psotka, Mitchell A.
    Krumholz, Harlan
    Fiuzat, Mona
    O'Connor, Christopher M.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (20) : 2051 - 2062
  • [42] A primer in artificial intelligence in cardiovascular medicine
    Benjamins, J. W.
    Hendriks, T.
    Knuuti, J.
    Juarez-Orozco, L. E.
    van der Harst, P.
    NETHERLANDS HEART JOURNAL, 2019, 27 (09) : 392 - 402
  • [43] Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
    Mitsala, Athanasia
    Tsalikidis, Christos
    Pitiakoudis, Michail
    Simopoulos, Constantinos
    Tsaroucha, Alexandra K.
    CURRENT ONCOLOGY, 2021, 28 (03) : 1581 - 1607
  • [44] Artificial intelligence: A new tool in surgeon's hand
    Gupta, Amit
    Singla, Tanuj
    Chennatt, Jaine John
    David, Lena Elizabath
    Ahmed, Shaik Sameer
    Rajput, Deepak
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2022, 11 (01) : 93
  • [45] Artificial Intelligence in Cardiovascular Atherosclerosis Imaging
    Zhang, Jia
    Han, Ruijuan
    Shao, Guo
    Lv, Bin
    Sun, Kai
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [46] Using Artificial Intelligence in Infection Prevention
    Fitzpatrick, Fidelma
    Doherty, Aaron
    Lacey, Gerard
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2020, 12 (02) : 135 - 144
  • [47] Open source as a gateway to artificial intelligence
    Balnaves, Edmund
    SOUTH AFRICAN JOURNAL OF LIBRARIES AND INFORMATION SCIENCE, 2024, 90 (02)
  • [48] Theranostics and artificial intelligence: new frontiers in personalized medicine
    Bilgin, Gokce Belge
    Bilgin, Cem
    Burkett, Brian J.
    Orme, Jacob J.
    Childs, Daniel S.
    Thorpe, Matthew P.
    Halfdanarson, Thorvardur R.
    Johnson, Geoffrey B.
    Kendi, Ayse Tuba
    Sartor, Oliver
    THERANOSTICS, 2024, 14 (06): : 2367 - 2378
  • [49] Artificial intelligence in gastrointestinal endoscopy - Evolution to a new era
    Ortiz, Oswaldo
    Fernandez-Esparrach, Gloria
    Daca, Maria
    Pellise, Maria
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (10) : 605 - 615
  • [50] Artificial intelligence and cardiovascular imaging: A win-win combination
    Badano, Luigi P.
    Keller, Daria M.
    Muraru, Denisa
    Torlasco, Camilla
    Parati, Gianfranco
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 24 (04) : 214 - 223